dc.contributor.author | Turkay, S | |
dc.contributor.author | Baskin, E | |
dc.contributor.author | Dener, S | |
dc.contributor.author | Gultekin, A | |
dc.contributor.author | Tanzer, F | |
dc.contributor.author | Sekreter, E | |
dc.date.accessioned | 2019-07-27T12:10:23Z | |
dc.date.accessioned | 2019-07-28T10:38:45Z | |
dc.date.available | 2019-07-27T12:10:23Z | |
dc.date.available | 2019-07-28T10:38:45Z | |
dc.date.issued | 1996 | |
dc.identifier.issn | 0041-4301 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12418/11880 | |
dc.description | WOS: A1996VK96400004 | en_US |
dc.description | PubMed ID: 8827898 | en_US |
dc.description.abstract | Six children suffering from epilepsy refractory to conventional anti-convulsive therapy were treated with high-dose intravenous immune globulin (IVIG) (200 mg/kg three times per week, repeated after three weeks). In four children clinical and EEG findings markedly improved, while a partial response was noted in the other cases. These results suggest that high-dose intravenous immune globulin may have a beneficial effect in the treatment of intractable epilepsy. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | TURKISH J PEDIATRICS | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | intractable epilepsy | en_US |
dc.subject | intravenous immune globulin (IVIG) | en_US |
dc.title | Immune globulin treatment in intractable epilepsy of childhood | en_US |
dc.type | article | en_US |
dc.relation.journal | TURKISH JOURNAL OF PEDIATRICS | en_US |
dc.identifier.volume | 38 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.endpage | 305 | en_US |
dc.identifier.startpage | 301 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |